123 related articles for article (PubMed ID: 35382931)
1. Neoadjuvant tyrosine kinase inhibitor therapy for patients with gastrointestinal stromal tumor: A propensity-matched analysis.
Wong LH; Sutton TL; Sheppard BC; Corless CL; Heinrich MC; Mayo SC
Am J Surg; 2022 Jul; 224(1 Pt B):624-628. PubMed ID: 35382931
[TBL] [Abstract][Full Text] [Related]
2. Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors.
Bednarski BK; Araujo DM; Yi M; Torres KE; Lazar A; Trent JC; Cormier JN; Pisters PW; Lev DC; Pollock RE; Feig BW; Hunt KK
Ann Surg Oncol; 2014 Aug; 21(8):2499-505. PubMed ID: 24639192
[TBL] [Abstract][Full Text] [Related]
3. Utilization of Neoadjuvant Therapy in Gastrointestinal Stromal Tumors of the Stomach: Analysis of the 2006-2018 National Cancer Database.
Kelly CH; Sipok A; Landry JP; Ramsey L; Joyce CJ; Gnerlich JL
J Gastrointest Surg; 2023 Sep; 27(9):1794-1803. PubMed ID: 37316761
[TBL] [Abstract][Full Text] [Related]
4. Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy.
Roland CL; Bednarski BK; Watson K; Torres KE; Cormier JN; Wang WL; Lazar AJ; Somaiah N; Hunt KK; Feig BW
J Surg Oncol; 2018 Apr; 117(5):879-885. PubMed ID: 29448300
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant therapy for gastrointestinal stromal tumors: A propensity score-weighted analysis.
Marqueen KE; Moshier E; Buckstein M; Ang C
Int J Cancer; 2021 Jul; 149(1):177-185. PubMed ID: 33634858
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.
Rutkowski P; Gronchi A; Hohenberger P; Bonvalot S; Schöffski P; Bauer S; Fumagalli E; Nyckowski P; Nguyen BP; Kerst JM; Fiore M; Bylina E; Hoiczyk M; Cats A; Casali PG; Le Cesne A; Treckmann J; Stoeckle E; de Wilt JH; Sleijfer S; Tielen R; van der Graaf W; Verhoef C; van Coevorden F
Ann Surg Oncol; 2013 Sep; 20(9):2937-43. PubMed ID: 23760587
[TBL] [Abstract][Full Text] [Related]
7. Hepatic metastases in gastrointestinal stromal tumors: oncologic outcomes with curative-intent hepatectomy, resection of treatment-resistant disease, and tyrosine kinase inhibitor therapy alone.
Sutton TL; Walker BS; Billingsley KG; Sheppard BC; Corless CL; Heinrich MC; Mayo SC
HPB (Oxford); 2022 Jun; 24(6):986-993. PubMed ID: 34924291
[TBL] [Abstract][Full Text] [Related]
8. The effect of neoadjuvant imatinib therapy on outcome and survival in rectal gastrointestinal stromal tumors: A multiinstitutional study.
Yang W; Liu Q; Lin G; Zhang B; Cao H; Zhao Y; Xia L; Feng F; Xiong Z; Hu J; Ye Y; Tao K; Zhang P
J Surg Oncol; 2021 Dec; 124(7):1128-1135. PubMed ID: 34324197
[TBL] [Abstract][Full Text] [Related]
9. Surgical Management of Metastatic Gastrointestinal Stromal Tumors.
Yonkus JA; Alva-Ruiz R; Grotz TE
Curr Treat Options Oncol; 2021 Mar; 22(5):37. PubMed ID: 33743084
[TBL] [Abstract][Full Text] [Related]
10. Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome.
Cavnar MJ; Wang L; Balachandran VP; Antonescu CR; Tap WD; Keohan M; Singer S; Temple L; Nash GM; Weiser MR; Guillem JG; Aguilar JG; DeMatteo RP; Paty PB
Ann Surg Oncol; 2017 Dec; 24(13):3972-3980. PubMed ID: 29058144
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
[No Abstract] [Full Text] [Related]
12. Has the survival rate for surgically resected gastric gastrointestinal stromal tumors improved in the tyrosine kinase inhibitor era?
Pedroso FE; Raut CP; Xiao H; Yeo CJ; Koniaris LG
Ann Surg Oncol; 2012 Jun; 19(6):1748-58. PubMed ID: 22290567
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal Stromal Tumors: 10-Year Experience in Cancer Center-The Ottawa Hospital (TOH).
Alfagih A; AlJassim A; Alshamsan B; Alqahtani N; Asmis T
Curr Oncol; 2022 Sep; 29(10):7148-7157. PubMed ID: 36290839
[TBL] [Abstract][Full Text] [Related]
14. Radical resection versus local excision for low rectal gastrointestinal stromal tumor: A multicenter propensity score-matched analysis.
Wang T; Zhao Y; Wang M; Zhang P; Lin G; Liu Q; Feng F; Xiong Z; Hu J; Zhang B; Ye Y; Xia L; Tao K
Eur J Surg Oncol; 2021 Jul; 47(7):1668-1674. PubMed ID: 33581967
[TBL] [Abstract][Full Text] [Related]
15. Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor.
DeMatteo RP; Maki RG; Singer S; Gonen M; Brennan MF; Antonescu CR
Ann Surg; 2007 Mar; 245(3):347-52. PubMed ID: 17435539
[TBL] [Abstract][Full Text] [Related]
16. Role of surgery in patients with focally progressive gastrointestinal stromal tumors resistant to imatinib.
Gao X; Xue A; Fang Y; Shu P; Ling J; Qin J; Hou Y; Shen K; Sun Y; Qin X
Sci Rep; 2016 Mar; 6():22840. PubMed ID: 26946961
[TBL] [Abstract][Full Text] [Related]
17. Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.
Turley RS; Peng PD; Reddy SK; Barbas AS; Geller DA; Marsh JW; Tsung A; Pawlik TM; Clary BM
Cancer; 2012 Jul; 118(14):3571-8. PubMed ID: 22086856
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy comparison between laparoscopy and open surgery in the treatment of gastric gastrointestinal stromal tumors larger than 2 cm using multicenter propensity score matching method].
Wu X; Sun LD; Wang M; Zhang P; Yang ZL; Liang H; Tao KX; Cao H; Xu WT
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):888-895. PubMed ID: 32927514
[No Abstract] [Full Text] [Related]
19. Comparison of outcomes between neoadjuvant imatinib and upfront surgery in patients with localized rectal GIST: An inverse probability of treatment weighting analysis.
Ling JY; Ding MM; Yang ZF; Zhao YD; Xie XY; Shi LS; Wang HM; Cao WT; Zhang JW; Hu HB; Cai Y; Wang H; Deng YH
J Surg Oncol; 2021 Dec; 124(8):1442-1450. PubMed ID: 34494280
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant and neoadjuvant therapy for primary GIST.
Eisenberg BL; Smith KD
Cancer Chemother Pharmacol; 2011 Jan; 67 Suppl 1():S3-8. PubMed ID: 21116626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]